Wait a second! Emergency Use Authorization (EUA) is for a product a company wants to introduce to the market (prior to any rigorous testing) for an illness that has no other treatments available! That’s why they smeared HCQ, Ivermectin, and many other available medications that are effective against the rona. So they could push their vaxx. Now Merck wants an EUA for a rona pill? I thought the FDA approved a “vaxx” for the rona? So, there a “treatment” for the rona on the market so Merck shouldn’t get an EUA for their “pill”. They should have to go through all the steps to get their “pill” to market. Phase 1, 2, and 3 trials etc. No thanks Merck, I’ll just stick to generic Ivermectin!